NAS
GILD icon

Nykredit A/S’s Gilead Sciences GILD Stock Holding History

Nykredit A/S’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$141M Buy
+1,112,764
New +$147M 0.54% 42

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Nykredit A/S's GILD Position: Q2 2026 in Review

Nykredit A/S opened a new position in Gilead Sciences (GILD) in Q2 2026: 1,112,764 shares worth $141M. The stake represents 0.54% of the portfolio and ranks #42 among its holdings.

2,291 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Nykredit A/S held 1,112,764 shares of Gilead Sciences worth $141M as of Q2 2026.
  • Gilead Sciences was a new Nykredit A/S position in Q2 2026.
  • Gilead Sciences made up 0.54% of Nykredit A/S's portfolio in Q2 2026, its #42 holding.
  • 2,291 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Nykredit A/S's 13F filing for Q2 2026, filed 13 Aug 2026.